The most common persistent symptoms in patients with COVID-19 who were evaluated in the Internal Medicine polyclinic
Abstract
Objectives: To identify continuing symptoms of individuals in the post-COVID period. To begin with our study was planned to research the most common persistent symptoms in the post-COVID period, and additionally to research whether or not there were differences between the most frequent initial symptoms in the 1st, 2nd and 3rd waves of the pandemic.
Methods: Cases attending the internal medicine clinic infected with COVID-19 who were minimum 120 days past the infection were included in the study. The study was shaped by responses of cases to open-ended questions.
Results: From a total of 2,802 clinical attendances, 1,005 cases were included in the study. Of cases, 9.3% required clinical monitoring and 1.7% required intensive care during infection. The mean number of persistent symptoms was 1.38, with the most common persistent symptoms being 11.2% fatigue/tiredness, 6.1% shortness of breath, and 4.6% back and low back pain. Mean number of initial symptoms was 1.63, with the most common initial symptoms being 21.2% fatigue, 19.4% fever and 19.1% headache. Persistent chest pain was most common among those infected in the 1st wave, while there were no other significant differences observed between pandemic waves.
Conclusions: The most common persistent symptoms were consistent with the general literature data; however, our condition of minimum 120 days past infection allowed a range of symptoms to ameliorate. Our results are more realistic in this way. A range of rare persistent symptoms emerging in our results were not encountered in the literature, while our study is unique as there is no other study comparing pandemic periods.
Keywords
References
- 1. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-23.
- 2. Perlman S. Another decade, another coronavirus. N Engl J Med 2020;382:760-2.
- 3. DiToro A, Bozzani A, Tavazzi G, Urtis M, Giuliani L, Pizzoccheri R, et al. Long COVID: long-term effects. Eur Heart J Suppl 2021;23(Suppl E):E1-5.
- 4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, het al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9.
- 5. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603-5.
- 6. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al; ARC Study Group. Long-COVID: a cross-sectional study of persistings ymptoms, biomarker and imaging abnormalities following hospitalization for COVID-19. Thorax 2021;76:396-8.
- 7. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021;93:1013-22.
- 8. Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al. The clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM 2020;113:657-65.
Details
Primary Language
English
Subjects
Internal Diseases
Journal Section
Research Article
Publication Date
January 4, 2023
Submission Date
April 27, 2022
Acceptance Date
August 19, 2022
Published in Issue
Year 2023 Volume: 9 Number: 1